4//SEC Filing
Chesworth Richard 4
Accession 0000899243-21-009410
CIK 0001815442other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:52 PM ET
Size
5.5 KB
Accession
0000899243-21-009410
Insider Transaction Report
Form 4
Chesworth Richard
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-01+60,000→ 60,000 totalExercise: $48.46Exp: 2031-02-28→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments over three (3) years following the Grant Date, with the first installment vesting on April 1, 2021.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001821188
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:52 PM ET
- Size
- 5.5 KB